These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 22916185

  • 1. High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China.
    Zhou YH, Yao ZH, Liu FL, Li H, Jiang L, Zhu JW, Zheng YT.
    PLoS One; 2012; 7(8):e42937. PubMed ID: 22916185
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML.
    BMC Public Health; 2011 May 19; 11():351. PubMed ID: 21595969
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M.
    Int J Infect Dis; 2010 Jan 19; 14(1):e28-33. PubMed ID: 19464218
    [Abstract] [Full Text] [Related]

  • 9. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
    Shapatava E, Nelson KE, Tsertsvadze T, del Rio C.
    Drug Alcohol Depend; 2006 Apr 19; 82 Suppl 1():S35-8. PubMed ID: 16769443
    [Abstract] [Full Text] [Related]

  • 10. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M.
    BMC Infect Dis; 2006 Jun 08; 6():93. PubMed ID: 16762050
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A, Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J.
    Int J Drug Policy; 2011 Mar 08; 22(2):145-52. PubMed ID: 21146392
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China.
    Zhang C, Yang R, Xia X, Qin S, Dai J, Zhang Z, Peng Z, Wei T, Liu H, Pu D, Luo J, Takebe Y, Ben K.
    J Acquir Immune Defic Syndr; 2002 Feb 01; 29(2):191-6. PubMed ID: 11832691
    [Abstract] [Full Text] [Related]

  • 14. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y, Liu Y, Zou X, Chen W, Ling L.
    BMJ Open; 2017 Jul 13; 7(7):e015524. PubMed ID: 28710214
    [Abstract] [Full Text] [Related]

  • 15. [Prevalence of HIV and HCV among injecting drug users (IDUs) in Yunnan, China].
    Li D, Zheng X, Zhang G.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr 13; 15(2):74-5. PubMed ID: 7522968
    [Abstract] [Full Text] [Related]

  • 16. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
    Quan VM, Go VF, Nam le V, Bergenstrom A, Thuoc NP, Zenilman J, Latkin C, Celentano DD.
    AIDS Care; 2009 Jan 13; 21(1):7-16. PubMed ID: 19085215
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sardu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G.
    J Med Virol; 2005 Jul 13; 76(3):311-7. PubMed ID: 15902712
    [Abstract] [Full Text] [Related]

  • 19. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD, Hagan H, Garfein RS, Sabin K, Weinbaum C, Thiede H.
    J Urban Health; 2007 May 13; 84(3):436-54. PubMed ID: 17356901
    [Abstract] [Full Text] [Related]

  • 20. [Epidemiologic studies on HCV and HBV infections among intravenous drug users in the area with high HIV infection].
    Cheng H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct 13; 14(5):275-8. PubMed ID: 8137408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.